CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: acetamiprid
Accession: CHEBI:39163
browse the term
Definition: A carboxamidine that is acetamidine in which the amino hydrogens are substituted by a (6-chloropyridin-3-yl)methyl and a methyl group while the hydrogen attached to the imino nitrogen is replaced by a cyano group.
Synonyms: exact_synonym: N-[(6-chloropyridin-3-yl)methyl]-N'-cyano-N-methylethanimidamide
related_synonym: Formula=C10H11ClN4; InChI=1S/C10H11ClN4/c1-8(14-7-12)15(2)6-9-3-4-10(11)13-5-9/h3-5H,6H2,1-2H3; InChIKey=WCXDHFDTOYPNIE-UHFFFAOYSA-N; N-((6-chloro-3-pyridinyl)methyl)-N'-cyano-N-methylethanimidamide; SMILES=CN(Cc1ccc(Cl)nc1)C(C)=NC#N
xref: Beilstein:8546705; CAS:160430-64-8
xref_mesh: MESH:C464485
xref: PMID:24620941; PMID:24840877; PMID:25373182; Reaxys:8546705
G
Actrt2
actin-related protein T2
decreases expression
EXP
acetamiprid results in decreased expression of ACTRT2 mRNA
CTD
PMID:27782041
NCBI chr 5:165,236,092...165,237,492
Ensembl chr 5:165,236,086...165,237,629
G
Asap2
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2
increases expression
EXP
acetamiprid results in increased expression of ASAP2 mRNA
CTD
PMID:27782041
NCBI chr 6:40,658,201...40,821,017
Ensembl chr 6:40,657,880...40,820,975
G
B3gnt9
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9
increases expression
EXP
acetamiprid results in increased expression of B3GNT9 mRNA
CTD
PMID:27782041
NCBI chr19:33,129,740...33,134,048
Ensembl chr19:33,128,142...33,132,344
G
Cacna1h
calcium voltage-gated channel subunit alpha1 H
increases expression
EXP
acetamiprid results in increased expression of CACNA1H mRNA
CTD
PMID:27782041
NCBI chr10:14,390,104...14,448,204
Ensembl chr10:14,390,113...14,448,376
G
Cacng1
calcium voltage-gated channel auxiliary subunit gamma 1
decreases expression
EXP
acetamiprid results in decreased expression of CACNG1 mRNA
CTD
PMID:27782041
NCBI chr10:92,652,924...92,665,612
Ensembl chr10:92,652,614...92,665,783
G
Card11
caspase recruitment domain family, member 11
increases expression
EXP
acetamiprid results in increased expression of CARD11 mRNA
CTD
PMID:27782041
NCBI chr12:13,620,979...13,758,115
Ensembl chr12:13,621,087...13,758,112
G
Cat
catalase
decreases activity
ISO
acetamiprid results in decreased activity of CAT protein
CTD
PMID:31935421
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Chrna4
cholinergic receptor nicotinic alpha 4 subunit
decreases expression
ISO
acetamiprid results in decreased expression of CHRNA4 mRNA
CTD
PMID:30103633
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
G
Chrna7
cholinergic receptor nicotinic alpha 7 subunit
decreases expression
ISO
acetamiprid results in decreased expression of CHRNA7 mRNA
CTD
PMID:30103633
NCBI chr 1:116,715,286...116,837,223
Ensembl chr 1:116,714,711...116,837,240
G
Chrnb2
cholinergic receptor nicotinic beta 2 subunit
decreases expression multiple interactions
ISO EXP
acetamiprid results in decreased expression of CHRNB2 acetamiprid results in increased activity of [NACHRA1 protein co-treated with CHRNB2 protein]; acetamiprid results in increased activity of [NACHRA8 protein co-treated with CHRNB2 protein]
CTD
PMID:16981889 PMID:25459289 PMID:27669271
NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
multiple interactions decreases expression
EXP ISO
Vitamin E inhibits the reaction [acetamiprid results in decreased expression of CYP11A mRNA]; Vitamin E inhibits the reaction [acetamiprid results in decreased expression of CYP11A protein] acetamiprid results in decreased expression of CYP11A1 mRNA; acetamiprid results in decreased expression of CYP11A1 protein
CTD
PMID:28395332 PMID:30103633
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
decreases expression
ISO
acetamiprid results in decreased expression of CYP17A1 mRNA
CTD
PMID:30103633
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
G
Dcdc2
doublecortin domain containing 2
increases expression decreases expression
EXP
acetamiprid results in increased expression of DCDC2 mRNA acetamiprid results in decreased expression of DCDC2 mRNA
CTD
PMID:27782041
NCBI chr17:39,845,952...40,031,781
Ensembl chr17:39,845,952...40,030,743
G
Des
desmin
decreases expression
EXP
acetamiprid results in decreased expression of DES mRNA
CTD
PMID:27782041
NCBI chr 9:76,850,979...76,858,695
Ensembl chr 9:76,850,982...76,858,699
G
F2rl2
coagulation factor II (thrombin) receptor-like 2
increases expression
EXP
acetamiprid results in increased expression of F2RL2 mRNA
CTD
PMID:27782041
NCBI chr 2:26,972,054...26,977,098
Ensembl chr 2:26,972,054...26,977,098
G
Fasn
fatty acid synthase
increases expression multiple interactions
EXP
acetamiprid results in increased expression of FASN protein Folic Acid inhibits the reaction [acetamiprid results in increased expression of FASN protein]
CTD
PMID:35124148
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Gpt
glutamic--pyruvic transaminase
increases activity multiple interactions
EXP
acetamiprid results in increased activity of GPT protein Folic Acid inhibits the reaction [acetamiprid results in increased activity of GPT protein]
CTD
PMID:35124148
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Hsd17b1
hydroxysteroid (17-beta) dehydrogenase 1
decreases expression
ISO
acetamiprid results in decreased expression of HSD17B1 mRNA
CTD
PMID:30103633
NCBI chr10:86,009,728...86,011,928
Ensembl chr10:86,009,728...86,011,927
G
Hspb7
heat shock protein family B (small) member 7
decreases expression
EXP
acetamiprid results in decreased expression of HSPB7 mRNA
CTD
PMID:27782041
NCBI chr 5:153,727,782...153,731,268
Ensembl chr 5:153,727,588...153,731,266
G
Iqcf1
IQ motif containing F1
decreases expression
EXP
acetamiprid results in decreased expression of IQCF1 mRNA
CTD
PMID:27782041
NCBI chr 8:107,129,462...107,133,242
Ensembl chr 8:107,130,704...107,133,249
G
Lhb
luteinizing hormone subunit beta
multiple interactions increases expression
EXP
Vitamin E inhibits the reaction [acetamiprid results in increased expression of LHB protein]
CTD
PMID:28395332
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Lhcgr
luteinizing hormone/choriogonadotropin receptor
decreases expression
ISO
acetamiprid results in decreased expression of LHR mRNA
CTD
PMID:30103633
NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:5,661,871...5,724,521
G
Lmod2
leiomodin 2
decreases expression
EXP
acetamiprid results in decreased expression of LMOD2 mRNA
CTD
PMID:27782041
NCBI chr 4:53,067,428...53,075,124
Ensembl chr 4:53,067,428...53,075,120
G
Mb
myoglobin
decreases expression
EXP
acetamiprid results in decreased expression of MB mRNA
CTD
PMID:27782041
NCBI chr 7:108,759,903...108,767,134
Ensembl chr 7:108,759,904...108,767,383
G
Mcmdc2
minichromosome maintenance domain containing 2
increases expression
EXP
acetamiprid results in increased expression of MCMDC2 mRNA
CTD
PMID:27782041
NCBI chr 5:9,291,967...9,337,526
Ensembl chr 5:9,298,101...9,338,300
G
Mki67
marker of proliferation Ki-67
decreases expression
ISO
acetamiprid results in decreased expression of MKI67 mRNA
CTD
PMID:30103633
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Myog
myogenin
decreases expression
EXP
acetamiprid results in decreased expression of MYOG mRNA
CTD
PMID:27782041
NCBI chr13:45,745,455...45,748,044
Ensembl chr13:45,745,436...45,748,039
G
Nags
N-acetylglutamate synthase
decreases expression
EXP
acetamiprid results in decreased expression of NAGS mRNA
CTD
PMID:27782041
NCBI chr10:87,098,330...87,102,465
Ensembl chr10:87,098,330...87,102,465
G
Napb
NSF attachment protein beta
increases expression
EXP
acetamiprid results in increased expression of NAPB mRNA
CTD
PMID:27782041
NCBI chr 3:136,132,248...136,179,225
Ensembl chr 3:136,133,428...136,179,345
G
Ndufaf2
NADH:ubiquinone oxidoreductase complex assembly factor 2
decreases expression
EXP
acetamiprid results in decreased expression of NDUFAF2 mRNA
CTD
PMID:27782041
NCBI chr 2:39,535,680...39,647,378
Ensembl chr 2:39,535,689...39,647,316
G
Olr825
olfactory receptor 825
decreases expression
EXP
acetamiprid results in decreased expression of OLR825 mRNA
CTD
PMID:27782041
NCBI chr 4:149,673,586...149,674,569
Ensembl chr 4:149,669,618...149,678,130
G
Olr94
olfactory receptor 94
decreases expression
EXP
acetamiprid results in decreased expression of OLR94 mRNA
CTD
PMID:27782041
NCBI chr 1:157,748,451...157,749,422
Ensembl chr 1:157,748,451...157,749,422
G
Phf21b
PHD finger protein 21B
increases expression
EXP
acetamiprid results in increased expression of PHF21B mRNA
CTD
PMID:27782041
NCBI chr 7:115,913,704...115,984,215
Ensembl chr 7:115,915,412...115,984,215
G
Plac8
placenta associated 8
increases expression
EXP
acetamiprid results in increased expression of PLAC8 mRNA
CTD
PMID:27782041
NCBI chr14:9,052,601...9,074,264
Ensembl chr14:9,063,048...9,074,264
G
Slc22a1
solute carrier family 22 member 1
increases activity
ISO
acetamiprid results in increased activity of SLC22A1 protein
CTD
PMID:31364238
NCBI chr 1:48,076,657...48,103,679
Ensembl chr 1:48,076,666...48,103,678
G
Slc22a2
solute carrier family 22 member 2
decreases activity
ISO
acetamiprid results in decreased activity of SLC22A2 protein
CTD
PMID:31364238
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Slc22a8
solute carrier family 22 member 8
decreases activity
ISO
acetamiprid results in decreased activity of SLC22A8 protein
CTD
PMID:31364238
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Slc45a3
solute carrier family 45, member 3
increases expression
EXP
acetamiprid results in increased expression of SLC45A3 mRNA
CTD
PMID:27782041
NCBI chr13:43,407,293...43,427,588
Ensembl chr13:43,407,293...43,427,588
G
Slco1b2
solute carrier organic anion transporter family member 1B2
decreases expression
EXP
acetamiprid results in decreased expression of SLCO1B2 mRNA
CTD
PMID:27782041
NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981
G
Star
steroidogenic acute regulatory protein
decreases expression multiple interactions
EXP ISO
acetamiprid results in decreased expression of STAR mRNA; acetamiprid results in decreased expression of STAR protein Vitamin E inhibits the reaction [acetamiprid results in decreased expression of STAR mRNA]; Vitamin E inhibits the reaction [acetamiprid results in decreased expression of STAR protein]
CTD
PMID:28395332 PMID:30103633
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
G
Tada2b
transcriptional adaptor 2B
increases expression
EXP
acetamiprid results in increased expression of TADA2B mRNA
CTD
PMID:27782041
NCBI chr14:74,279,286...74,290,758
Ensembl chr14:74,279,217...74,290,755
G
Tnni2
troponin I2, fast skeletal type
decreases expression
EXP
acetamiprid results in decreased expression of TNNI2 mRNA
CTD
PMID:27782041
NCBI chr 1:197,595,012...197,597,554
Ensembl chr 1:197,594,813...197,597,560
G
Top2a
DNA topoisomerase II alpha
decreases expression
ISO
acetamiprid results in decreased expression of TOP2A mRNA
CTD
PMID:30103633
NCBI chr10:83,946,186...83,975,694
Ensembl chr10:83,945,735...83,976,874
G
Unc45b
unc-45 myosin chaperone B
decreases expression
EXP
acetamiprid results in decreased expression of UNC45B mRNA
CTD
PMID:27782041
NCBI chr10:67,845,382...67,873,389
Ensembl chr10:67,845,462...67,873,389
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all